Prasvas'S Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.91 M
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
About Prasvas'S Pharma
Prasvas's Pharma Private Limited (PPPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 April 1999 and has a history of 25 years and ten months. Its registered office is in Agra, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.91 M, as per Ministry of Corporate Affairs (MCA) records.
Jaswant Singh and Mohini Agarwal serve as directors at the Company.
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231UP1999PTC024375
- Company No.
024375
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Apr 1999
- Date of AGM
20 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Prasvas'S Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaswant Singh  | Director | 21-Jan-2019 | Current |
| Mohini Agarwal | Director | 04-Jul-2011 | Current |
Financial Performance of Prasvas'S Pharma.
Prasvas'S Pharma Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Prasvas'S Pharma?
In 2017, Prasvas'S Pharma had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Manasvi Merchandise Private LimitedJaswant Singh and Mohini Agarwal are mutual person
- Bliss Aluminiums Private Limited
Jaswant Singh and Mohini Agarwal are mutual person
- Naveen Organic Farms Private Limited
Jaswant Singh and Mohini Agarwal are mutual person
- Sudarshan Infradev Private Limited
Jaswant Singh and Mohini Agarwal are mutual person
- Strength Buildcon Private Limited
Jaswant Singh and Mohini Agarwal are mutual person
- Saket Automobiles Private Limited
Jaswant Singh and Mohini Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prasvas'S Pharma?
Unlock and access historical data on people associated with Prasvas'S Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prasvas'S Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prasvas'S Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
